Presenter Information
Kathleen Dawson, PharmD Candidate 2020, School of Pharmacy
Choniece Phillips, PharmD Candidate 2020, School of Pharmacy
Lindsay Roberts, PharmD Candidate 2020, School of Pharmacy
Megan Bookser, PharmD
Jamie McConaha, PharmD, School of Pharmacy
Abstract
Abstract
Objective
The focus of this study was to evaluate the impact of pharmacist’ intervention on quality metrics focusing on patients with a diagnosis of diabetes mellitus type II (T2DM) not currently prescribed statin therapy.
Methods
This retrospective cohort investigational study was conducted in four lowest performing office locations of a nineteen regional primary care physician group practice. Inclusion criteria were diagnosis of T2DM without active statin therapy. Data was excluded from analysis for patients younger than age 40 or older than age 75, or if the most recent LDL documented was less than 70 mg/dL. Recommendations for initiation of statin therapy were sent electronically to the patient’s primary care physician via EMR software.
Results
Preliminary screening in March 2018 demonstrated a total of 2206 patients diagnosed with T2DM, for which 790 patients were not actively prescribed statin therapy. 468 patients were identified as eligible for statin therapy. Endpoint analysis in November 2018 showed that of the initial 468 patients who were eligible for a statin, 74 had been prescribed a statin, and 23 patients fell out of study criteria.
Implications
The efficacy of statin interventions is supported by the practice entity’s improvement in STAR ratings for the Medicare Advantage populations, in which two major payer groups saw increases in statin use in diabetes measures. Standard of care combined with pharmacist-led interventions correlated to a 4-STAR rating for the practice entity as of October 2018. Pharmacists can play an important role in helping physicians meet these quality metrics.
School
School of Pharmacy
Advisor
Dr. Jamie McConaha; Dr. Megan Bookser
Submission Type
Paper
Publication Date
April 2019
Included in
Other Pharmacy and Pharmaceutical Sciences Commons, Pharmacy Administration, Policy and Regulation Commons
Improving Physician Office Quality Measures by Evaluating Statin Prescribing in Type 2 Diabetic Patients
Abstract
Objective
The focus of this study was to evaluate the impact of pharmacist’ intervention on quality metrics focusing on patients with a diagnosis of diabetes mellitus type II (T2DM) not currently prescribed statin therapy.
Methods
This retrospective cohort investigational study was conducted in four lowest performing office locations of a nineteen regional primary care physician group practice. Inclusion criteria were diagnosis of T2DM without active statin therapy. Data was excluded from analysis for patients younger than age 40 or older than age 75, or if the most recent LDL documented was less than 70 mg/dL. Recommendations for initiation of statin therapy were sent electronically to the patient’s primary care physician via EMR software.
Results
Preliminary screening in March 2018 demonstrated a total of 2206 patients diagnosed with T2DM, for which 790 patients were not actively prescribed statin therapy. 468 patients were identified as eligible for statin therapy. Endpoint analysis in November 2018 showed that of the initial 468 patients who were eligible for a statin, 74 had been prescribed a statin, and 23 patients fell out of study criteria.
Implications
The efficacy of statin interventions is supported by the practice entity’s improvement in STAR ratings for the Medicare Advantage populations, in which two major payer groups saw increases in statin use in diabetes measures. Standard of care combined with pharmacist-led interventions correlated to a 4-STAR rating for the practice entity as of October 2018. Pharmacists can play an important role in helping physicians meet these quality metrics.